Literature DB >> 2383596

A factor from damaged rat kidney stimulates collagen biosynthesis by mesangial cells.

K Ohyama1, J M Seyer, R Raghow, A H Kang.   

Abstract

Rats were administered CCl4, a well-defined nephrotoxin, for 20 weeks to produce glomerular sclerosis. Tubular degeneration and necrosis with interstitial fibrosis was clearly evident by histological examination. Kidneys were homogenized in phosphate-buffered saline and a collagen synthesis-stimulating factor was isolated by Sephadex G-50 gel filtration. The 5 kDa component stimulated both type I and type IV procollagen synthesis by mesangial cells and type I procollagen synthesis by rat skin fibroblasts. In each cell type, 2-6-fold increases in procollagen protein production or cell proliferation was noted. The steady-state levels of mRNA encoding for procollagen alpha 1(I) and procollagen alpha 1(IV) chains in mesangial cells were determined by by hybridization to their corresponding cDNA clones. The type I procollagen mRNA was elevated 1.4-fold compared to a 1.6-fold increase in mRNA encoding for type IV procollagen. The similar properties and chemical characteristics of this fibrogenic factor with a factor from fibrotic liver suggests they are the same and that a common endogenous collagen synthesis stimulator may be present in fibrosing organs, thus providing a driving force for collagen over-production.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2383596     DOI: 10.1016/0167-4889(90)90010-b

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  2 in total

1.  Markers of collagen synthesis and degradation are increased in serum in severe sepsis: a longitudinal study of 44 patients.

Authors:  Fiia Gäddnäs; Marjo Koskela; Vesa Koivukangas; Juha Risteli; Aarne Oikarinen; Jouko Laurila; Juha Saarnio; Tero Ala-Kokko
Journal:  Crit Care       Date:  2009-04-09       Impact factor: 9.097

2.  Long-Term Structural and Functional Myocardial Adaptations in Healthy Living Kidney Donors: A Pilot Study.

Authors:  Diego Bellavia; Alessandro Cataliotti; Francesco Clemenza; Cesar Hernandez Baravoglia; Angelo Luca; Marcello Traina; Bruno Gridelli; Tullio Bertani; John C Burnett; Cesare Scardulla
Journal:  PLoS One       Date:  2015-11-10       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.